Ecsedy Jeffrey 4
4 · Ikena Oncology, Inc. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Ecsedy Jeffrey
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-02-01+100,000→ 100,000 totalExercise: $1.36Exp: 2034-02-01→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest and become exercisable on January 1, 2025, with the remainder vesting in 36 substantially equal monthly installments thereafter.